Clinical Trial Management
Full-service project management for Phase I–IV studies — one accountable team from protocol to clinical study report.
- Study plans, timelines and risk management
- Vendor and site coordination
- Budget and payment management
Clinical Research Organization · Site Management · India
Clinical research done right — ethically, rigorously and on time.
Ethica Research partners with pharmaceutical, biotech and medical device sponsors to deliver Phase I–IV studies with GCP-trained teams, rapid start-up and inspection-ready quality.
- ICH-GCP E6(R3) aligned
- CDSCO · NDCT Rules 2019
- Ethics-committee approved studies
- Participant safety first
ICH-GCP
Aligned processes from day one
Who we are
An ethics-first research partner built for dependable execution
Ethica Research brings sponsors, CROs, investigators and patients together around one shared goal: credible evidence generated the right way. Our clinical operations, regulatory and quality teams work as an extension of yours — from the first feasibility call to the final clinical study report.
Every study we take on is run to ICH-GCP and the New Drugs and Clinical Trials Rules, 2019, with participant safety, informed consent and data integrity treated as non-negotiable.
- Investigator partnerships across key therapeutic areas
- GCP-trained clinical research coordinators
- Parallel regulatory and ethics committee submissions
- Transparent enrollment and data-quality reporting
What we do
End-to-end clinical research capabilities
From the first feasibility call to the final study report, choose full-service support or the specific capabilities you need.
Explore all servicesSite Management (SMO)
Research-ready sites with experienced investigators and dedicated, GCP-trained coordinators — managed to one quality standard.
- Experienced PIs and sub-investigators
- Dedicated clinical research coordinators
- Standardised SOPs across sites
Feasibility & Site Selection
Evidence-based feasibility in 5–7 business days so you choose sites that will actually recruit.
- Protocol and eligibility criteria review
- Patient-pool and competing-study analysis
- Investigator interest and experience assessment
Patient Recruitment & Retention
Ethical, targeted recruitment strategies and participant support programs that keep enrollment on plan.
- Study-specific recruitment plans
- Pre-screening and referral networks
- Ethics-approved awareness materials
Regulatory & Ethics Services
CDSCO, CTRI and ethics committee submissions handled by specialists who know the process inside out.
- Clinical trial applications to CDSCO
- CTRI registration and updates
- Ethics committee submissions and renewals
Clinical Monitoring & Quality Assurance
Risk-based monitoring and independent quality assurance that keep your data inspection-ready.
- Site initiation, monitoring and close-out visits
- Risk-based and centralised monitoring
- Source data verification and review
The Ethica difference
Speed matters. Ethics and quality matter more.
We were founded on a simple belief: research done the right way is also research done well. That conviction shapes how we select sites, train teams and report progress.
Partner with usEthics before everything
Participant safety, valid informed consent and data integrity are never traded for speed. Our processes are built around them.
Investigator-led quality
Experienced principal investigators and GCP-certified coordinators run every site, supported by an independent QA function.
Rapid, transparent start-up
Parallel submissions, pre-negotiated site agreements and standard budgets help studies go live sooner.
Partnership, not outsourcing
We co-own timelines with you, escalate early and stay accountable from first contact to final report.
Insights
Guides and updates from our research team
Welcome to Ethica Research
Ethica Research is now online. Here is who we are, what we do and how sponsors, investigators and participants can reach us.
Read articleClinical Trial Phases Explained: Phase I to Phase IV
New medicines are tested in stages, and each phase answers a different question. A plain-language guide to what happens in Phase I, II, III…
Read articleWhat the New Drugs and Clinical Trials Rules, 2019 Mean for Sponsors
A practical overview of the key provisions of India's NDCT Rules, 2019 — approval timelines, ethics committee registration and participant…
Read articleReady to start your next study in India?
Share your protocol synopsis and we will return a site feasibility assessment and start-up plan — confidentially and within five business days.
- Confidential review under NDA
- Response within one business day
- Direct PI and site assessment